Lombardi Stories
Lombardi Women Celebrate Breast Cancer Patients and Researchers
October 4th, 2024
Use the link above to search for the following keyword:
– Breast cancer
More clinical trials are available on NIH’s national clinical trial database.
You will be redirected to our clinical partner, MedStar Health.
Whether you are in need of breast cancer screening, a consultation with a breast surgeon or genetic testing, or are interested in breast health generally, Georgetown Lombardi is committed to connecting you to the appropriate breast health services and clinical trials. We are dedicated to providing the best professional care, delivered with compassion, for all patients and to provide you with the most current breast health information and resources. In conjunction with cutting-edge breast cancer care provided by clinical partner MedStar Health, we offer a program of innovative clinical trials and a full range of supportive care services to improve patient health and quality of life.
Current information about breast cancer (Breast Cancer Treatment, Male Breast Cancer, Breast Cancer and Pregnancy, Inflammatory Breast Cancer), incidence and survival statistics, treatment options, causes and prevention, coping strategies, clinical trials, and research is available online from the National Cancer Institute at the National Institutes of Health.
The Nina Hyde Center for Breast Cancer Research promotes advanced breast cancer research at the Georgetown Lombardi Comprehensive Cancer Center. The research done at the Nina Hyde Center makes Georgetown one of the leading institutions for breast cancer research.
Georgetown Lombardi’s world-renowned research faculty are discovering breast cancer risk factors, designing effective prevention strategies, and learning how to detect this cancer earlier. They are developing and testing the cancer treatments of tomorrow — targeted therapies that will improve both survival and quality of life.
News Release
New Study: Analysis Supports New Recommendation to Begin Mammogram Screening at 40
April 30th, 2024
News Release
The Aspirin Conundrum: Navigating Negative Results, Age, Aging Dynamics and Equity
April 29th, 2024